DMD and Duchenne muscular dystrophy: The goal of exon skipping therapy is to restore the disrupted open reading frame (ORF) of the dystrophin gene transcripts in DMD patients, allowing them to make a Becker’s muscular dystrophy-like protein (Figure 2) (Niks and Aartsma-Rus, 2017).